Enzyme activity: PNG1 cleaves N-linked glycans from misfolded glycoproteins via its transglutaminase-like domain .
Subcellular localization: Primarily nuclear, with cytoplasmic presence in yeast (S. cerevisiae) and Drosophila .
Conservation: Homologs identified in humans (NGLY1), mice, plants (Neurospora crassa), and flies (D. melanogaster) .
Western blotting: Detects PNG1 in yeast (42.5 kDa), Drosophila (44.7 kDa), and mammalian lysates .
Immunofluorescence: Localizes PNG1 to nuclei in yeast and Drosophila ISCs .
Activity profiling: Antibody-based pulldowns validate enzymatic activity loss in mutants (e.g., png1-1 D285N/E239D) .
| Assay | Sample Type | Result | Source |
|---|---|---|---|
| Activity rescue | Yeast Δpng1 | 10-50% activity in D179E/P180A mutants | |
| ENGase inhibition | Drosophila midgut | Rabeprazole restores ISC proliferation |
Neurodegeneration: PNG1 dysfunction correlates with polyubiquitinated protein accumulation, mimicking NGLY1 deficiency disorders .
Cancer pathways: PNG1 knockdown alters ROS levels and CncC/NF-E2-related signaling in Drosophila epithelial cells .
Therapeutic targets: ENGase inhibitors (e.g., Rabeprazole) rescue PNG1-related phenotypes, suggesting combinatorial treatment strategies .